AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7987431 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal hygiene education program for 2 months
Number of subjects: 12
Study 7987431 — intervention group
Group type: COMPARATOR
Intervention: Control group of teachers
Number of subjects: 12
Study 2563955 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 21
Study 2563955 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 21
Study 2563955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 1106848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibromodulcitol
Number of subjects: 0
Study 1106848 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 0
Study 31883044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked hyaluronan (cHA) gel applied at the end of hysteroscopy and 5-7 days after operation
Number of subjects: 306
Study 31883044 — intervention group
Group type: COMPARATOR
Intervention: Standard hysteroscopy
Number of subjects: 306
Study 31172172 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole eggs (100 g, ∼2 whole eggs per day)
Number of subjects: 20
Study 31172172 — intervention group
Group type: COMPARATOR
Intervention: Yolk-free eggs (100 g, ∼2 yolk-free eggs per day)
Number of subjects: 20
Study 28063841 — intervention group
Group type: EXPERIMENTAL
Intervention: External physical vibration lithecbole
Number of subjects: 173
Study 28063841 — intervention group
Group type: COMPARATOR
Intervention: Retrograde intrarenal surgery
Number of subjects: 173
Study 26043564 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at positive points (liniao point and Qihai (RN6) combined with Guanyuan (RN4), Zhongji (RN3), Shenshu (BL23), Zusanli (ST36), Sanyinjiao (SP6), Taixi (K13))
Number of subjects: 107
Study 26043564 — intervention group
Group type: COMPARATOR
Intervention: Negative acupressure at sham-acupoints
Number of subjects: 107
Study 26043564 — intervention group
Group type: COMPARATOR
Intervention: Conventional sitz bath
Number of subjects: 107
Study 23757297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial neurotomy
Number of subjects: 16
Study 23757297 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin (BTX)
Number of subjects: 16
Study 22086091 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) epidural steroids
Number of subjects: 42
Study 22086091 — intervention group
Group type: COMPARATOR
Intervention: Interlaminar (IL) epidural steroids
Number of subjects: 42
Study 18435479 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Number of subjects: 42
Study 18435479 — intervention group
Group type: COMPARATOR
Intervention: Placebo (eucalyptus oil)
Number of subjects: 42
Study 16448475 — intervention group
Group type: EXPERIMENTAL
Intervention: LGG-supplemented formula
Number of subjects: 120
Study 16448475 — intervention group
Group type: COMPARATOR
Intervention: Regular formula
Number of subjects: 120
Study 12760625 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of action performed by a human actor with a distractor present
Number of subjects: 0
Study 12760625 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of action performed by a human actor without a distractor
Number of subjects: 0
Study 12760625 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch trials where the actor was seated but no action was demonstrated
Number of subjects: 0
Study 12760625 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring gaze direction of the actor
Number of subjects: 0
Study 11327415 — intervention group
Group type: EXPERIMENTAL
Intervention: Norian SRS (self-setting hydroxyapatite) with wrist immobilization for 2 weeks (n=12)
Number of subjects: 23
Study 11327415 — intervention group
Group type: COMPARATOR
Intervention: External fixation with immobilization for 5 weeks (n=11)
Number of subjects: 23
Study 9863113 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-wave millimeter microwave (QWMM) irradiation starting 10 days after operation and combined with chemotherapy on the 16th day (Group A)
Number of subjects: 62
Study 9863113 — intervention group
Group type: COMPARATOR
Intervention: Q-wave millimeter microwave (QWMM) irradiation starting immediately after chemotherapy induced peripheral WBC reduction (Group B)
Number of subjects: 62
Study 9863113 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effective rate of both groups
Number of subjects: 62
Study 8347733 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg body wt. daily s.c. GM-CSF
Number of subjects: 44
Study 8347733 — intervention group
Group type: COMPARATOR
Intervention: 5 micrograms/kg body wt. daily s.c. GM-CSF
Number of subjects: 44
Study 8347733 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosages of GM-CSF
Number of subjects: 44
Study 2939636 — intervention group
Group type: EXPERIMENTAL
Intervention: prednicarbate 0.25% in emulsifiable greasy ointment without water
Number of subjects: 383
Study 2939636 — intervention group
Group type: EXPERIMENTAL
Intervention: prednicarbate 0.25% in w/o emulsion (ointment)
Number of subjects: 383
Study 2939636 — intervention group
Group type: EXPERIMENTAL
Intervention: prednicarbate 0.25% in o/w emulsion (cream)
Number of subjects: 383
Study 2939636 — intervention group
Group type: EXPERIMENTAL
Intervention: prednicarbate 0.25% in various vehicles
Number of subjects: 383
Study 31981587 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar content signage
Number of subjects: 3034
Study 31981587 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Rating signage
Number of subjects: 3034
Study 31981587 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic health warning signage
Number of subjects: 3034
Study 31981587 — intervention group
Group type: COMPARATOR
Intervention: No signage (control)
Number of subjects: 3034
Study 28749734 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter orange (500 mg capsules)
Number of subjects: 156
Study 28749734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender (500 mg capsules)
Number of subjects: 156
Study 28749734 — intervention group
Group type: COMPARATOR
Intervention: Control (starch, 500 mg capsules)
Number of subjects: 156
Study 28606422 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (walking), 3 times per week for 24 weeks
Number of subjects: 39
Study 28606422 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 39
Study 25233298 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 135
Study 25233298 — intervention group
Group type: COMPARATOR
Intervention: Fever control
Number of subjects: 135
Study 23283539 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment and exercises
Number of subjects: 60
Study 23283539 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonophoresis and exercises
Number of subjects: 60
Study 23283539 — intervention group
Group type: COMPARATOR
Intervention: Exercises only (Control)
Number of subjects: 60
Study 20054280 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected C/G ratio
Number of subjects: 21
Study 20054280 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal responses
Number of subjects: 21
Study 20054280 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented responses
Number of subjects: 21
Study 20054280 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw and corrected amplitudes of c-VEMP
Number of subjects: 21
Study 18202563 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (submaximal cycling at 60% of HRpeak and low‐intensity resistance training at < 50% 1RM)
Number of subjects: 17
Study 18202563 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 17
Study 16827385 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous osteochondral transplantation
Number of subjects: 25
Study 16827385 — intervention group
Group type: COMPARATOR
Intervention: Cleaning and drilling procedures
Number of subjects: 25
Study 15257735 — intervention group
Group type: EXPERIMENTAL
Intervention: Access flap surgery followed by root surface and defect debridement using an Er:YAG laser (KEY3) (160 mJ, 10 Hz)
Number of subjects: 23
Study 15257735 — intervention group
Group type: COMPARATOR
Intervention: Access flap surgery followed by root surface and defect debridement using hand and ultrasonic instruments
Number of subjects: 23
Study 10905076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureaplasma urealyticum vaginosis
Number of subjects: 166
Study 10905076 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 166
Study 9224864 — intervention group
Group type: EXPERIMENTAL
Intervention: MENTAL
Number of subjects: 8
Study 9224864 — intervention group
Group type: EXPERIMENTAL
Intervention: LOUD
Number of subjects: 8
Study 9224864 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 8
Study 8467888 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased speed of movement
Number of subjects: 0
Study 8467888 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous resistive load
Number of subjects: 0
Study 3950448 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of spiral bacteria in specimens with gastritis (n=39)
Number of subjects: 50
Study 3950448 — intervention group
Group type: COMPARATOR
Intervention: Presence of spiral bacteria in normal specimens (n=7)
Number of subjects: 50
Study 3950448 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of spiral bacteria in gastric ulcer patients (n=17)
Number of subjects: 50
Study 31937322 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous reduction of flow and FiO2
Number of subjects: 100
Study 31937322 — intervention group
Group type: COMPARATOR
Intervention: Flow reduction (FR) first
Number of subjects: 100
Study 31937322 — intervention group
Group type: COMPARATOR
Intervention: FiO2 reduction (OR) first
Number of subjects: 100
Study 29947695 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) with two pressure levels, once a day for 60 min from the 1st to the 3rd postoperative day (POD)
Number of subjects: 50
Study 29947695 — intervention group
Group type: COMPARATOR
Intervention: Control group received guidelines regarding posture, early ambulation, and cough stimuli
Number of subjects: 50
Study 26748736 — intervention group
Group type: EXPERIMENTAL
Intervention: Concise Health Risk Tracking Self‐Report (CHRT)
Number of subjects: 482
Study 26748736 — intervention group
Group type: COMPARATOR
Intervention: Columbia Suicide Severity Rating Scale (CSSRS)
Number of subjects: 482
Study 24733770 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist case management (active prescribing)
Number of subjects: 279
Study 24733770 — intervention group
Group type: COMPARATOR
Intervention: Nurse-led case management (screening and feedback)
Number of subjects: 279
Study 22197301 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face personalized feedback intervention (PFI) with a live interviewer
Number of subjects: 152
Study 22197301 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered personalized feedback intervention (PFI) with a video interviewer
Number of subjects: 152
Study 22197301 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive assessment condition
Number of subjects: 152
Study 22197301 — intervention group
Group type: COMPARATOR
Intervention: Minimal assessment-only condition
Number of subjects: 152
Study 20064578 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap in a seat (NS)
Number of subjects: 36
Study 20064578 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap in a bed (NB)
Number of subjects: 36
Study 20064578 — intervention group
Group type: COMPARATOR
Intervention: No-nap (NN)
Number of subjects: 36
Study 18312805 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored telephone intervention
Number of subjects: 598
Study 18312805 — intervention group
Group type: COMPARATOR
Intervention: Standard print intervention
Number of subjects: 598
Study 11574357 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Cannula (NC) 2-4 L/min
Number of subjects: 190
Study 11574357 — intervention group
Group type: COMPARATOR
Intervention: Room Air
Number of subjects: 190
Study 9745969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine hydrochloride tablets after lunch and before bedtime for 2 months
Number of subjects: 300
Study 9745969 — intervention group
Group type: COMPARATOR
Intervention: Control group treatments (imipramine hydrochloride, desmoporessin, ritaline, cetiprin, or behavioral therapy)
Number of subjects: 300
Study 8186113 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper vapour laser (CVL) at 578 nm, mean fluence 18.2 J/cm2, mean pulse width 50 ms
Number of subjects: 43
Study 8186113 — intervention group
Group type: COMPARATOR
Intervention: Pulsed tunable dye laser (PTDL) at 585 nm, 6.5 J/cm2
Number of subjects: 43
Study 3373404 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.1 mg/kg)
Number of subjects: 122
Study 3373404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 3373404 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (low-weight subgroup)
Number of subjects: 122
Study 3373404 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (high-weight subgroup)
Number of subjects: 122
Study 3373404 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high-weight subgroup)
Number of subjects: 122
Study 30600137 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (QW) 2 mg
Number of subjects: 295
Study 28160326 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival provocation test with peanut extract
Number of subjects: 102
Study 28160326 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral peanut provocation (double-blind placebo-controlled)
Number of subjects: 102
Study 28160326 — intervention group
Group type: COMPARATOR
Intervention: Control group (peanut-tolerant children)
Number of subjects: 102
Study 25535318 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) workshop plus behavioral family intervention (BFI)
Number of subjects: 59
Study 25535318 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 59
Study 23235135 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surfactant administration (n = 74)
Number of subjects: 153
Study 23235135 — intervention group
Group type: COMPARATOR
Intervention: Late surfactant administration (n = 79)
Number of subjects: 153
Study 21645196 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent, adjuvanted vaccine against influenza A/H1N1 (n=16)
Number of subjects: 24
Study 21645196 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (control group, n=8)
Number of subjects: 24
Study 18981932 — intervention group
Group type: EXPERIMENTAL
Intervention: Child CBT
Number of subjects: 128
Study 18981932 — intervention group
Group type: COMPARATOR
Intervention: Family CBT
Number of subjects: 128
Study 18981932 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 128
Study 16781986 — intervention group
Group type: EXPERIMENTAL
Intervention: Home administration of intravenous methylprednisolone
Number of subjects: 138
Study 16781986 — intervention group
Group type: COMPARATOR
Intervention: Outpatient administration of intravenous methylprednisolone
Number of subjects: 138
Study 12612196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse transit time (PTT) measurement
Number of subjects: 34
Study 12612196 — intervention group
Group type: COMPARATOR
Intervention: EEG arousal measurement
Number of subjects: 34
Study 10720861 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% plus epinephrine (5 microg/ml)
Number of subjects: 69
Study 10720861 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 69
Study 9196086 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast (80 mg twice daily)
Number of subjects: 12
Study 9196086 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg twice daily)
Number of subjects: 12
Study 9196086 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of zafirlukast and loratadine
Number of subjects: 12
Study 9196086 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study 1347280 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine 500 mg bd
Number of subjects: 227
Study 1347280 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine 1 g bd
Number of subjects: 227
Study 31849027 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (4 or 6 mg/d)
Number of subjects: 48
Study 31849027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 29767739 — intervention group
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 2519
Study 29767739 — intervention group
Group type: COMPARATOR
Intervention: qHPV vaccine
Number of subjects: 2519
Study 26555602 — intervention group
Group type: EXPERIMENTAL
Intervention: Algisyl with standard medical therapy (SMT)
Number of subjects: 78
Study 26555602 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) alone
Number of subjects: 78
Study 26555602 — intervention group
Group type: EXPERIMENTAL
Intervention: Algisyl with SMT
Number of subjects: 78
Study 23822617 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-based programme combining CBT with job skills training
Number of subjects: 109
Study 23822617 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 109
Study 22480818 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg/d
Number of subjects: 205
Study 22480818 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/d (after week 4 for non-responders)
Number of subjects: 205
Study 22480818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 20873934 — intervention group
Group type: EXPERIMENTAL
Intervention: Negations in descriptions of stereotype-inconsistent behavior
Number of subjects: 0
Study 20873934 — intervention group
Group type: EXPERIMENTAL
Intervention: Negations in descriptions of behavior
Number of subjects: 0
Study 18785413 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat granules with microskin in mixed grafting (volume ratio 1:1)
Number of subjects: 20
Study 18785413 — intervention group
Group type: COMPARATOR
Intervention: Autologous microskin grafting only
Number of subjects: 20
Study 18785413 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat granules with microskin in mixed grafting
Number of subjects: 20
Study 16823364 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual insulin dose
Number of subjects: 16
Study 16823364 — intervention group
Group type: COMPARATOR
Intervention: Reduced insulin dose (1/3 reduction)
Number of subjects: 16
Study 12966478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 50 mg
Number of subjects: 0
Study 12966478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 100 mg
Number of subjects: 0
Study 12966478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 20 to 100 mg
Number of subjects: 0
Study 12966478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium <20 mg
Number of subjects: 0
Study 12966478 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 30 mg
Number of subjects: 0
Study 12966478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10839762 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (3-month course)
Number of subjects: 3300
Study 10839762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3300
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose dobutamine (5-10 micrograms/kg/min over 5 min)
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose dobutamine (20-40 micrograms/kg/min over 3 min)
Number of subjects: 51
Study 8800985 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole (0.56 mg/kg over 4 min + 0.28 mg/kg over 2 min)
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Late spontaneous functional recovery
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity of dobutamine
Number of subjects: 51
Study 8800985 — intervention group
Group type: COMPARATOR
Intervention: Sensitivity of dipyridamole
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity of dobutamine
Number of subjects: 51
Study 8800985 — intervention group
Group type: COMPARATOR
Intervention: Specificity of dipyridamole
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive predictive value of dobutamine
Number of subjects: 51
Study 8800985 — intervention group
Group type: COMPARATOR
Intervention: Positive predictive value of dipyridamole
Number of subjects: 51
Study 8800985 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative predictive value of dobutamine
Number of subjects: 51
Study 8800985 — intervention group
Group type: COMPARATOR
Intervention: Negative predictive value of dipyridamole
Number of subjects: 51
Study 1516979 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg clomiphene citrate daily for 6 months
Number of subjects: 190
Study 1516979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 6549194 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol 0.5 micrograms every 6 hr during dietary intake of 22.3 mmoles Ca/day
Number of subjects: 6
Study 6549194 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol 0.5 micrograms every 6 hr during dietary intake of 9.3 mmoles Ca/day
Number of subjects: 6
Study 6549194 — intervention group
Group type: COMPARATOR
Intervention: Control (before calcitriol administration) with dietary intake of 22.3 mmoles Ca/day
Number of subjects: 6
Study 6549194 — intervention group
Group type: COMPARATOR
Intervention: Control (before calcitriol administration) with dietary intake of 9.3 mmoles Ca/day
Number of subjects: 6
Study 31717571 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater intake of less healthful food groups (sweet snacks, salty snacks, and sweetened beverages)
Number of subjects: 868
Study 31717571 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater intake of sweet snacks
Number of subjects: 868
Study 31717571 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater intake of fruits
Number of subjects: 868
Study 29783095 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment initiated prior to release
Number of subjects: 199